Cronos Group Inc. (CRON)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$2.65
-2.04%
Mkt Cap $1.00B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $38.72M | $44.53M | +15.01% | $0.01 | -$0.00 | -147.00% | — | — |
| Q4 2025 Nov 6, 2025 | $38.43M | $36.34M | -5.45% | $0.02 | $0.07 | +250.00% | — | — |
| Q3 2025 Aug 7, 2025 | $37.34M | $32.36M | -13.34% | -$0.02 | -$0.10 | -400.00% | — | — |
| Q2 2025 May 8, 2025 | $31.66M | $22.65M | -28.44% | -$0.01 | $0.02 | +378.55% | — | — |
| Q1 2025 Feb 27, 2025 | $33.68M | $21.06M | -37.47% | -$0.01 | -$0.01 | +0.00% | — | — |
| Q4 2024 Nov 12, 2024 | $34.54M | $25.25M | -26.91% | -$0.01 | -$0.02 | -300.00% | — | — |
| Q3 2024 Aug 8, 2024 | $19.02M | $20.30M | +6.75% | -$0.00 | -$0.02 | -700.00% | — | — |
| Q2 2024 May 9, 2024 | $17.39M | $18.54M | +6.58% | -$0.01 | -$0.01 | -25.00% | — | — |
| Q1 2024 Feb 29, 2024 | $18.89M | $18.50M | -2.02% | -$0.01 | -$0.05 | -233.33% | — | — |
| Q4 2023 Nov 8, 2023 | $18.51M | $18.32M | -1.06% | -$0.00 | -$0.00 | -100.00% | — | — |
| Q3 2023 Aug 8, 2023 | $16.91M | $14.36M | -15.11% | -$0.01 | -$0.02 | -68.78% | — | — |
| Q2 2023 May 9, 2023 | $17.96M | $14.89M | -17.10% | -$0.04 | -$0.03 | +25.00% | — | — |
| Q1 2023 Feb 28, 2023 | $22.20M | $17.06M | -23.17% | -$0.05 | -$0.14 | -180.00% | — | — |
| Q4 2022 Nov 7, 2022 | $24.99M | $15.28M | -38.87% | -$0.06 | -$0.07 | -16.67% | — | — |
| Q3 2022 Aug 9, 2022 | $27.99M | $17.90M | -36.04% | -$0.05 | -$0.05 | +0.00% | — | — |
| Q2 2022 May 10, 2022 | $23.97M | $20.02M | -16.48% | -$0.08 | -$0.09 | -12.50% | — | — |
| Q1 2022 Mar 1, 2022 | $23.58M | $20.23M | -14.21% | -$0.10 | -$0.36 | -260.00% | — | — |
| Q1 2022 Feb 18, 2022 | — | $16.10M | — | — | $0.16 | — | — | — |
| Q3 2021 Aug 6, 2021 | $11.16M | $12.60M | +12.95% | -$0.07 | -$0.09 | -28.57% | — | — |
| Q2 2021 May 7, 2021 | $32.79M | $10.03M | -69.40% | -$0.08 | -$0.12 | -50.00% | — | — |